INS and metabolic disease: Additionally, previous studies have demonstrated that SRT501[30,31,53] and SRT1720[32,54], like calorie restriction [4,8], enhance oxidative metabolism, protect against diet induced obesity, increase exercise endurance, and improve glucose and insulin homeostasis in rodent models of metabolic disease.